A survey of 71 European centres showed variation in clinical practice regarding periprocedural antithrombotic therapy for device implantation and AF ablation, with some consistency with guidelines.
Cross-Sectional (n=71)
Yes
This EP Wire surveyed clinical practice with regard to the use of antithrombotic therapy in relation to device implantation (pacemakers, ICT, resynchronization therapy) and atrial fibrillation ablation in 71 centres-members of the European Heart Rhythm Association research network. The results of this survey show variation in clinical practice, but reassuringly some consistency with guidelines and consensus recommendations on the management of periprocedure (devices, ablation) antithrombotic therapy.
Lip et al. (Tue,) conducted a cross-sectional in Device implantation and atrial fibrillation ablation (n=71). Periprocedural antithrombotic therapy was evaluated on Clinical practice with regard to the use of antithrombotic therapy. A survey of 71 European centres showed variation in clinical practice regarding periprocedural antithrombotic therapy for device implantation and AF ablation, with some consistency with guidelines.